检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘宁波[1] 马莉[2] 杨国仁[2] 李明焕[3] 胡漫[3] 韦光胜[3] 付正[2] 于金明[3]
机构地区:[1]天津医科大学肿瘤医院放疗科,300060 [2]山东省肿瘤医院PET/CT中心 [3]山东省肿瘤医院特需一科
出 处:《中华核医学杂志》2009年第4期230-233,共4页Chinese Journal of Nuclear Medicine
基 金:国家高技术研究发展计划(2007AA02Z437)
摘 要:目的评价^18F-脱氧葡萄糖(FDG)PET/CT检测恶性肿瘤骨转移的应用价值。方法回顾性分析经^18F-FDG PET/CT诊断的689例恶性肿瘤患者的资料,按颈椎、胸椎、腰椎、骶尾椎、骨盆、肩胛骨和锁骨、长骨、胸骨、肋骨及颅骨将机体骨骼分为10个区域,记录每个区域的骨转移情况。根据同机CT进一步区分转移灶的病变性质(破骨性或成骨性),比较同机CT、^18F-FDG PET及^18F-FDG PET/CT诊断骨转移的灵敏度、特异性及准确性。计算阳性病灶的最大标准摄取值(SUVmax)。患者不同性别间年龄差异采用χ^2检验,诊断率的比较采用MeNemar检验。结果共有91例患者442个区域被确定有骨转移,PET/CT诊断骨转移患者的灵敏度、特异性和准确性分别为94.5%(86/91)、97.8%(585/598)和97.4%(671/689),高于同机CT的79.1%(72/91),91.8%(549/598)和90.1%(621/689)(χ^2=20.049,148.890,168.792,P:0.000);PET/CT诊断病灶骨转移的灵敏度、特异性和准确性分别为95.0%(420/442),97.2%(455/468)和96.2%(875/919),高于同机CT的81.0%(358/442),90.4%(423/468)和85.8%(781/910)(χ^2=98.673,125.691,220.375,P=0.000)。同机CT共诊断出99个成骨性和197个破骨性病变。PET真阳性病灶SUVmax为6.7±3.0,假阳性病灶SUVmax为3.7±1.3(χ^2=463.120,P=0.000);成骨性病变SUVmax为4.9±2.0,破骨性病变SUVmax为7.4±3.1(χ^2=327.175,P:0.000)。结论同机CT和^18F-FDG PET图像的结合提高了PET/CT诊断恶性肿瘤骨转移的能力;同机CT能精确定位病变,并可区分转移病灶的成骨或破骨性质。Objective The aim of this retrospective study was to understand the role of ^18 F-fluorodeoxyglucose (FDG) PET/CT in detecting bone metastasis in various cancers. Methods Six hundred and eighty-nine cancer patients who had ^18F-FDG PET/CT were included. The diagnosis of bone metastasis was based on matched findings of FDG-avid lesion on PET and characteristic morphological changes on CT. The sensitivity, specificity and accuracy of CT, and PET/CT were calculated and the results were statistically analyzed ( McNemar test). Results Ninety-one patients with 442 regions were diagnosed to have bone metastases. On patient base analysis, the sensitivity, specificity, and accuracy of hybrid CT for detecting bone metastases were 79.1% (72/91), 91.8% (549/598), 90. 1% (621/689) and were 94.5% (86/91), 97.8% (585/598), 97.4% (671/689) for PET/CT (χ^2 = 20. 049, 148. 890, 168. 792, all P = 0. 000). On lesion base analysis, the sensitivity, specificity, and accuracy of hybrid CT for detecting bone metastases were 81.0% (358/442), 90.4% (423/468), 85.8% (781/910) and were 95.0% (420/442), 97.2% (455/468), 96.2% (875/910) for PET/CT (χ^2 = 98. 673, 125. 691, 220. 375, all P = 0. 000). The maximum standardized uptake value ( SUVmax ) of PET true positive and false positive lesions were 6.7± 3.0 and 3.7 ±2. 3 respectively (χ^2= 463. 120, P = 0.000). The SUVmax of osteoblastic and osteolytic lesions were 4.9 ±2.0 and 7.4±3.1, respectively (χ^2 =327. 175, P =0.000). Conclusions It is worth noting that ^18F-FDG PET/CT is a novel tool to evaluate bone metastasis and its performances due to the combination of PET and CT. Hybrid CT has a high value in providing precise location of the metastatic sites.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.118.104.28